Moteur de recherche d’entreprises européennes
Financement de l’UE (196 591 €) : Les glycanes enrobent les nanoparticules comme un bouclier biocompatible pour augmenter la stabilité colloïdale des nanoparticules et moduler leur réponse … Hor20/03/2020 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Les glycanes enrobent les nanoparticules comme un bouclier biocompatible pour augmenter la stabilité colloïdale des nanoparticules et moduler leur réponse immunologique.
Nanomedicine is currently the most studied and promising topics in the field of biomedical technology, which is focused on developing nanoparticles. The reason for this is that these materials present unique properties such as size, high ratio area/ volume, chemical reactivity, that offer potential solutions for many of the current challenges in diagnosis, therapy and vaccines on several diseases. However, the safe use of NPs in clinical applications is not established yet. At present, the NPs have limited stability in complex cell media, enhanced recognition by the immunological system and reduced targeting efficacy as a result of the protein corona formation. Studies in Dr. Monopoli´s laboratory at RSCI have demonstrated that glycosylation of the protein corona plays an important role in maintaining the colloidal stability of nanoparticles and influences nanoparticle-cell interactions. The proposed research programme will utilize the combination of interdisciplinary and intersectoral approaches (synthetic chemistry, physical chemistry, glycoprofiling and proteomics, an inter-sectoral secondment (CIC biomaGUNE, Prof Sergio Moya to learn fluorescence correlation spectroscopy and test the NP targeting efficacy) to synthetise a range of nanoparticles (NPs) decorated with synthetic and naturally occurring glycans (hence, Glyco-NPs) in order to: 1), increase the NPs' colloidal stability, 2) attenuate the unspecific protein interaction and 3) increase the NPs circulation half-life into the bloodstream. Together with my supervisor, we have designed a training plan that includes new research (glycoprofiling and bio-nanointeractions), and transferable (project management, leadership, innovation) skills.
| Royal College of Surgeons in Ireland | 196 591 € |
https://cordis.europa.eu/project/id/894656
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Royal College of Surgeons in Ireland Educational Institution, Dublin, Irlande.
Les visualisations de "Royal College of Surgeons in Ireland - Financement de l’UE (196 591 €) : Les glycanes enrobent les nanoparticules comme un bouclier biocompatible pour augmenter la stabilité colloïdale des nanoparticules et moduler leur réponse …"
sont mis à disposition par
North Data
et peuvent être réutilisées selon les termes de la licence
Creative Commons CC-BY.
